Evidence map›Paper›PMID 38622893›Full record

Observational studyBrain and behavior2024

Multicenter registry study of cerebral venous thrombosis in china (RETAIN-CH): Rationale and design.

Hetao Bian, Xia Wang, Lan Liu, Feng Yan, Shan Lu, Wen Hui, Chen Zhou, Jiangang Duan, Min Li, Jian Chen and 4 more

Registry-linked trialOpen access · goldAbstract readObservational StudyMulticenter Study
In one paragraph

Observational study in Brain and behavior, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05448248 (A Registry Study of Cerebral Venous Sinus Thrombosis in China), which is not on this map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05448248 completednot on this map

A Registry Study of Cerebral Venous Sinus Thrombosis in China

TypeobservationalSponsorCapital Medical UniversityRan2022 to 2023Enrolled3,276ConditionsCerebral Vein Thrombosis, Cerebral Venous Sinus Thrombosis
3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 3 countries.

Hetao BianBeijing Institute for Brain Disorders, Capital Medical University, Beijing, China.
Xia WangThe George Institute for Global Health, University of New South Wales, Sydney, Australia.
Lan LiuSchool of Statistics, University of Minnesota at Twin Cities, Minneapolis, Minnesota, USA.
Feng YanDepartment of Neurosurgery, Xuanwu Hospital of Capital Medical University, Beijing, China.
Shan LuDepartment of Neurology and Psychiatry, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
Wen HuiDepartment of Science and Technology, West China Hospital of Sichuan University, Chengdu, Sichuan, China.
Chen ZhouBeijing Institute for Brain Disorders, Capital Medical University, Beijing, China.
Jiangang DuanDepartment of Emergency, Xuanwu Hospital of Capital Medical University, Beijing, China.
Min LiDepartment of Neurology, Xuanwu Hospital of Capital Medical University, Beijing, China.
Jian ChenDepartment of Neurosurgery, Xuanwu Hospital of Capital Medical University, Beijing, China.
Ran MengDepartment of Neurology, Xuanwu Hospital of Capital Medical University, Beijing, China.
Lei CaoThe General Office of Stroke Prevention Project Committee, National Health Commission of the People's Republic of China, Beijing, China.
Longde WangThe General Office of Stroke Prevention Project Committee, National Health Commission of the People's Republic of China, Beijing, China.
Xunming JiBeijing Institute for Brain Disorders, Capital Medical University, Beijing, China.ORCID 0000-0002-0527-2852
Capital Medical University · CNNational Health and Family Planning Commission · CNSichuan University · CNUniversity of Minnesota · USUNSW Sydney · AU

Funding

Beijing Science and Technology Planning Project Z181100001918026National Natural Science Foundation of China 82027802Talent Construction Fund of Beijing Institute of Brain Disorders PXM2020_014226_000004
6 · The paper itself

Abstract

background and rationaleCerebral venous thrombosis (CVT) is a rare cerebrovascular disorder that mainly affects young and middle-aged adults. Epidemiological data on the incidence, risk factors, diagnosis, treatment, and prognosis of CVT are lacking in China. In addition, there is a lack of evidence from large, multicenter, real-world studies on the efficacy and safety of endovascular.

aimTo understand the incidence, diagnosis and treatment status of CVT in China and to estimate the effectiveness and safety of endovascular treatment in the real-world.

methodsA multicenter, retrospective observational cohort study will be conducted on CVT patient records from 104 hospitals, between January 1, 2018 and June 30, 2022, identified using a 2-stage cluster sampling design based on per capita gross domestic product. Each enrolled participant is required to complete a further follow-up, which includes the current situation and the assessment at 3 and 12 months after discharge. STUDY OUTCOMES: The outcomes of this study will include the current status of the incidence, pathogenesis, etiology, clinical symptoms, diagnosis, and treatment of CVT in China, as well as the effectiveness and safety of endovascular treatment in the real-world. DISCUSSION: Results from this study will provide evidence on the incidence, specific risk factors, symptomatic and imaging features, and clinical outcomes of CVT in China as well as indicate whether endovascular treatment is superior to medical management alone for patients with acute CVT in the real-world.

trial registrationhttp://www. CLINICALTRIALS: gov. IDENTIFIER: NCT05448248.

Indexed as

Intracranial ThrombosisVenous ThrombosisAdultHumansMiddle AgedPrognosisRegistriesRetrospective Studiescerebral venous thrombosiscohort studyendovascular treatmentprotocolsafety

Identifiers

PMID38622893
PMCPMC11019244
OpenAlexW4394854066

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.